Suchita Shrestha
Lalitpur, WR, Nepal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Persistence of immune responses 5 years after vaccination with a single dose of typhoid conjugate vaccine (TCV) in Nepalese children.
Journal: Vaccine
Published: April 27, 2026
Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: March 05, 2026
8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.
Journal: The Lancet. Global health
Published: March 05, 2026
Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: An observational study.
Journal: The Journal of infection
Published: February 12, 2026
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Journal: PLoS medicine
Published: August 23, 2023
Dark and bright spots in the shadow of the pandemic: Rural livelihoods, social vulnerability, and local governance in India and Nepal.
Journal: World development
Published: May 01, 2021
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
Journal: The Lancet. Global health
Published: March 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026